Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies.
Esquirol A, Pascual MJ, Ortiz M, Piñana JL, Ferra C, Garcia Cadenas I, Vilades I, Brunet S, Martino R, Sierra J. Esquirol A, et al. Among authors: ferra c. Bone Marrow Transplant. 2017 Sep;52(9):1273-1279. doi: 10.1038/bmt.2017.111. Epub 2017 Jun 12. Bone Marrow Transplant. 2017. PMID: 28604667
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D, García-López J, Sureda A, Canals C, Ferra C, Cancelas JA, Berlanga JJ, Brunet S, Boqué C, Picón M, Torrico C, Amill B, Martino R, Martínez C, Martín-Henao G, Domingo-Albós A, Grañena A. Gallardo D, et al. Among authors: ferra c. Bone Marrow Transplant. 1997 Dec;20(11):945-52. doi: 10.1038/sj.bmt.1701008. Bone Marrow Transplant. 1997. PMID: 9422473
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C, de Sanjosé S, Lastra CF, Martí F, Mariño EL, Sureda A, Brunet S, Gallardo D, Berlanga JJ, García J, Grañena A. Ferrà C, et al. Bone Marrow Transplant. 1997 Dec;20(12):1075-80. doi: 10.1038/sj.bmt.1701023. Bone Marrow Transplant. 1997. PMID: 9466281 Clinical Trial.
Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A, Castellsagué X, Badell I, Ferra C, Ortega J, Brunet S, Puntí C, Sureda A, Picón M, Valls A, Rutllant M, García J. Grañena A, et al. Among authors: ferra c. Bone Marrow Transplant. 1999 Sep;24(6):621-7. doi: 10.1038/sj.bmt.1701957. Bone Marrow Transplant. 1999. PMID: 10490727
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings.
Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteiza J, Ferrá C, Zuazu J, Caballero D, Carvalhais A, Díez JL, Espigado I, Martínez C, Campilho F, Sanz MA, Sierra J, García-Conde J, Montserrat E; Spanish Group for Allogenic Peripheral Blood Transplantation. Urbano-Ispizua A, et al. Among authors: ferra c. Blood. 2001 Jan 15;97(2):383-7. doi: 10.1182/blood.v97.2.383. Blood. 2001. PMID: 11154212 Free article.
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.
Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, García-Conde J, Jarque I, Caballero MD, Ferrà C, López A, García-Laraña J, Cabrera R, Carrera D, Ruiz-Romero MD, León A, Rifón J, Díaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Altés A, López-Guillermo A, de la Serna J, Fernández-Rañada JM, Sierra J, Conde E; Grupo Español de Linformas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. Sureda A, et al. Among authors: ferra c. J Clin Oncol. 2001 Mar 1;19(5):1395-404. doi: 10.1200/JCO.2001.19.5.1395. J Clin Oncol. 2001. PMID: 11230484
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation.
Urbano-Ispizua A, Brunet S, Solano C, Moraleda JM, Rovira M, Zuazu J, de La Rubia J, Bargay J, Caballero D, Díez-Martín JL, Ojeda E, Pérez de Oteiza JP, Ferrá C, Espigado I, Alegre A, de La Serna J, Torres P, Riu C, Odriozola J, Rozman C, Sierra J, García-Conde J, Montserrat E; Spanish Group of Allo-PBT. Urbano-Ispizua A, et al. Among authors: ferra c. Bone Marrow Transplant. 2001 Aug;28(4):349-54. doi: 10.1038/sj.bmt.1703154. Bone Marrow Transplant. 2001. PMID: 11571506
131 results